17th International Workshop on Multiple Myeloma (IMW-17)
Dr. Steven Treon was one of the principal organizers of the 17th International Workshop on Multiple Myeloma, held on September 12-15 at the Hynes Convention Center in Boston MA, USA. Over 3,000 participants attended this event which covered the latest genomic advances, insights into immune and microenvironmental dysregulation, new drug targets and agents, immunotherapeutic approaches including Car T-cell therapies, and breaking results from early and large randomized clinical trials. Please visit the website for more information about this and other upcoming events regarding the research and treatment of multiple myeloma and related plasma cell disorders.
IMW-17 Promotional Video
This video was produced by SPARGO (who provided the A/V for the conference). It captures some of the visuals from the meeting, as well as the educational and social events at the Boston Museum of Fine Arts and the Boston Museum of Science.
https://www.youtube.com/watch?v=jsKrXND-nkU
Dr. Treon introduces IMW-17 at EHA 2019
Steven Treon, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, tells the Video Journal of Hematology & Oncology about The 17th International Myeloma Workshop, which was held in Boston on September 12-15, 2019. This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.
https://www.youtube.com/watch?v=JQhDRJ5pDIk
Dr. Treon introduces IMW-17 at COMy 2019
Steven Treon, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, gives the Video Journal of Hematology & Oncology exciting information on what to expect at the 2019 International Myeloma Workshop (IMW-17), which was held on the 12-15 September in Boston. This interview took place at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.
https://www.youtube.com/watch?v=tB5rHbpm_Ro
